Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global Women Health Therapeutics Market Research and Analysis 2015 - 2022 - Research and Markets

Research and Markets
Posted on: 03 Oct 17

The "Global Women Health Therapeutics Market Research and Analysis 2015 - 2022" report has been added to Research and Markets' offering.

Global women health therapeutics market is expected to witness a CAGR of around 4.4% during the forecasted period 2016-2022

In the healthcare industry, women health therapeutics market is a booming segment as every woman has to deal with some kind of gynecological disorder at some point of their lifetime. While most of the gynecological diseases can be cured with proper treatment but in certain cases they can prove fatal unless diagnosed at the right time. In present times, women health therapeutics market has notable pipeline of promising molecules at several stages of clinical development. Some of such molecules are AZD4901, romosozumab (AMG785), abaloparatide, elagolix, ASP1707, vaginorm and teriparatide.

The global women health therapeutics market has witnessed phenomenal growth in the last decade owing to the rising awareness among women and physicians about the health issues related to the female gender. Along with it, large number of pharmaceutical companies entering the market has substantially supported the market.

Rise in cases of infertility and increasing incidences of chronic disorders among women are seen as the key forces driving the growth of the global market. According to WHO, infertility in women is ranked as the 5th highest serious disability worldwide owing to which rise in need for infertility therapeutics can be seen in present times. Numerous facts and stats support the high infertility rate at global level. According to CDC, around 11.9% of women have ever received any kind of infertility services in their lifetime.

Key Topics Covered:

1. Report Summary

2. Market Overview and Insights

3. Market Determinant

4. Market Segmentation

5. Competitive Landscape

6. Regional Analysis

7. Company Profiles

  • Abbott Laboratories
  • Amgen, Inc.
  • Astellas Pharma Inc.
  • Bayer AG
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co., Inc.
  • Novartis International AG
  • Novogyne Pharmaceuticals
  • Novo Nordisk A/S
  • Pfizer, Inc.
  • Oasmia Pharmaceutical Company
  • Radius Health Company
  • Repros Therapeutics Inc.
  • Sanofi S.A.
  • Takeda Pharmaceutical Company Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Tsumura & Co.
  • Warner Chilcott Corp.
  • Zosano Pharma Inc.

For more information about this report visit https://www.researchandmarkets.com/research/7trppg/global_women

View source version on businesswire.com: http://www.businesswire.com/news/home/20170926006264/en/

Business Wire
www.businesswire.com

Last updated on: 03/10/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.